by Product (Diagnostic Devices, Monitoring Devices, and Consumables & Accessories), Indication (COPD and Asthma), and End User (Hospitals & Clinics, Homecare Settings, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global COPD and asthma diagnostic and monitoring device industry was estimated at $4.95 billion in 2019, and is anticipated to hit $8.20 billion by 2027, registering a CAGR of 6.3% from 2020 to 2027.
Drivers, restraints, and opportunities-
Daily exposure to environmental pollution, rise in population susceptible to indoor air pollutants, portability of the drug delivery devices, surge in population of active smokers, and increase in the number of surgeries drive the growth of the global asthma diagnostic and monitoring device sector. On the other hand, high costs of the device and stringent regulatory procedures impede the growth to some extent. However, high growth potential in emerging markets and increase in geriatric population are expected to create lucrative opportunities in the industry.